AstraZeneca in $560 m deal for respir...

AstraZeneca in $560 m deal for respiratory firm

There are 1 comment on the Seattle Times story from Jun 10, 2013, titled AstraZeneca in $560 m deal for respiratory firm. In it, Seattle Times reports that:

British drugmaker AstraZeneca PLC says it is to acquire Pearl Therapeutics Inc., a Redwood-City, California-based company involved in therapies for asthma and chronic obstructive pulmonary disease for at least $560 million.

Join the discussion below, or Read more at Seattle Times.

Since: Apr 13

Location hidden

#1 Jun 10, 2013
This sounds promising.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Atherton Discussions

Title Updated Last By Comments
Review: Senior Helpers (Mar '16) Fri John A 3
Re-Elect Judge Aaron Persky! Sep 7 Big Lumber 8
White Male Privilege May '16 It is True 4
News Beltramo's Wines & Spirits is closing its doors... May '16 Lindy 1
News LA Times Completely Botches Story on HSR Fares (May '15) May '15 cbloom57 1
News City Blows the Whistle on High-Speed Trains (Feb '15) Feb '15 CTYKE 1
News Bill Widmer named new Rancho Palos Verdes city ... (Dec '14) Dec '14 Are you serious 1

Atherton Jobs

More from around the web

Personal Finance

Atherton Mortgages